MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas

Mengya Zhao(China Pharmaceutical University), Shuzhen Wang(China Pharmaceutical University)
Frontiers in Oncology
March 17, 2022
Cited by 9


Related Papers